Aileen Burke, Jessica O'Driscoll, Mustapha Abubakar, Kathleen E Bennett, Emma Carmody, Fidelma Flanagan, Gretchen L Gierach, Maeve Mullooly
{"title":"A systematic review of determinants of breast cancer risk among women with benign breast disease.","authors":"Aileen Burke, Jessica O'Driscoll, Mustapha Abubakar, Kathleen E Bennett, Emma Carmody, Fidelma Flanagan, Gretchen L Gierach, Maeve Mullooly","doi":"10.1038/s41523-024-00703-w","DOIUrl":null,"url":null,"abstract":"<p><p>Benign breast disease (BBD) is associated with heterogeneous breast cancer risk. Identifying key breast cancer risk factors for this population may inform breast cancer prevention or early detection strategies. We systematically searched literature databases PubMed, Embase, Scopus, Web of Science, and the Cochrane Library to identify studies reporting associations of demographic, lifestyle, reproductive, and radiological factors with risk of breast cancer among women with biopsy-confirmed BBD. 67 studies met eligibility criteria. Variation was observed for study time period, exposure measurement, comparison groups, outcomes, and adjustment for confounders, precluding meta-analysis. The literature suggested positive risk associations for age at biopsy, family history, mammographic breast density, and time since biopsy, and no association for body mass index, alcohol, smoking, age at menarche, and use of hormonal contraceptives. More research is needed to understand risk factor associations among women with BBD, particularly studies that account for heterogeneity within BBD and breast cancer.</p>","PeriodicalId":19247,"journal":{"name":"NPJ Breast Cancer","volume":"11 1","pages":"16"},"PeriodicalIF":7.6000,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11829998/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Breast Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41523-024-00703-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Benign breast disease (BBD) is associated with heterogeneous breast cancer risk. Identifying key breast cancer risk factors for this population may inform breast cancer prevention or early detection strategies. We systematically searched literature databases PubMed, Embase, Scopus, Web of Science, and the Cochrane Library to identify studies reporting associations of demographic, lifestyle, reproductive, and radiological factors with risk of breast cancer among women with biopsy-confirmed BBD. 67 studies met eligibility criteria. Variation was observed for study time period, exposure measurement, comparison groups, outcomes, and adjustment for confounders, precluding meta-analysis. The literature suggested positive risk associations for age at biopsy, family history, mammographic breast density, and time since biopsy, and no association for body mass index, alcohol, smoking, age at menarche, and use of hormonal contraceptives. More research is needed to understand risk factor associations among women with BBD, particularly studies that account for heterogeneity within BBD and breast cancer.
良性乳腺疾病(BBD)与异质性乳腺癌风险相关。确定这一人群的主要乳腺癌危险因素可能为乳腺癌预防或早期发现策略提供信息。我们系统地检索了PubMed、Embase、Scopus、Web of Science和Cochrane Library等文献数据库,以确定在活检证实的BBD女性中,人口统计学、生活方式、生殖和放射学因素与乳腺癌风险相关的研究。67项研究符合资格标准。观察到研究时间段、暴露测量、对照组、结果和混杂因素调整的差异,排除了荟萃分析。文献提示活检年龄、家族史、乳房x光检查乳腺密度和活检后时间呈正相关,与体重指数、饮酒、吸烟、月经初潮年龄和使用激素避孕药无关。需要更多的研究来了解患BBD的女性之间的风险因素的关联,特别是研究BBD和乳腺癌之间的异质性。
期刊介绍:
npj Breast Cancer publishes original research articles, reviews, brief correspondence, meeting reports, editorial summaries and hypothesis generating observations which could be unexplained or preliminary findings from experiments, novel ideas, or the framing of new questions that need to be solved. Featured topics of the journal include imaging, immunotherapy, molecular classification of disease, mechanism-based therapies largely targeting signal transduction pathways, carcinogenesis including hereditary susceptibility and molecular epidemiology, survivorship issues including long-term toxicities of treatment and secondary neoplasm occurrence, the biophysics of cancer, mechanisms of metastasis and their perturbation, and studies of the tumor microenvironment.